Incyte Corporation
—- Market cap
- —
- Debt
- +$19.78B
- Cash
- −$3.38B
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: INCY stock price vs M: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at M's multiple
Needs M P/E.
Implied fair value · at INCY's multiple
Needs INCY P/E.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: INCY FY 2025 (ended Dec 31, 2025) · M FY 2026 (ended Jan 31, 2026). Fiscal years are not aligned.
Trendline
11 fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
INCYTE CORPORATION · implied price per share
Bear
-$7.58
Base
-$8.91
Bull
-$10.25
Macy's, Inc. · implied price per share
Bear
$7.82
Base
$9.21
Bull
$10.59
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
3.83x
0.50x
Net debt / EBITDA
Leverage against operating earnings
9.31x
0.78x
Cash and equivalents
Liquid reserves on the balance sheet
$3.38B
$1.25B
Total debt
Interest-bearing obligations outstanding
$19.78B
$2.44B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AMGEN INC
INCY vs AMGN
GILEAD SCIENCES, INC.
INCY vs GILD
VERTEX PHARMACEUTICALS INC / MA
INCY vs VRTX
REGENERON PHARMACEUTICALS, INC.
INCY vs REGN
BIOGEN INC.
INCY vs BIIB
TJX COMPANIES INC /DE/
INCY vs TJX
ROSS STORES, INC.
INCY vs ROST
KOHLS Corp
INCY vs KSS
NORDSTROM INC
INCY vs JWN
DILLARD'S, INC.
INCY vs DDS
Burlington Stores, Inc.
INCY vs BURL
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.